Table: Jcr Pharmaceuticals -2020/21 parent results

JCR Pharmaceuticals

13/05/2021 08:00

May 13 (Reuters)- 
          Jcr Pharmaceuticals Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             30.09           24.73                                
                 (+21.7 pct)     (+7.9 pct)                              
  Operating          8.64            3.29                                
                (+162.8 pct)     (-33.8 pct)                             
  Recurring          8.59            3.34                                
                (+157.1 pct)     (-33.6 pct)                             
  Net                7.08            2.74                                
                (+158.3 pct)     (-28.4 pct)                             
  EPS             57.33 yen       22.23 yen                              
  EPS Diluted     57.05 yen       22.10 yen                              
  Ann Div                         32.00 yen      16.00 yen               
  -Q2 Div         18.00 yen       15.00 yen      8.00 yen                
  -Q4 Div         7.50 yen        17.00 yen      8.00 yen                
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T